PSS Receives Surescripts(R) Certification For EDispense Software

JACKSONVILLE, Fla., Dec. 19, 2012 (GLOBE NEWSWIRE) -- PSS World Medical, Inc. (Nasdaq:PSSI) announced today that its eDispense software has been certified by Surescripts ^® for prescription routing. EDispense, part of the PSS in‑office pharmaceutical dispensing solution, will now be able to receive electronic prescriptions through the Surescripts network.

"We are committed to strengthening caregivers and improving patient convenience by enhancing the value of our point-of-care treatment solutions," explained Scott Helfrich, Vice President and General Manager of PSS Dispensing. "Connectivity to the Surescripts network increases efficiency and convenience in the dispensing process and ultimately helps to improve patient medication adherence. The streamlined workflow is integrated into the electronic e-prescription writing process within the caregiver's electronic health records (EHR) so that when they create an electronic prescription, the patient can easily choose to have it filled through the in-office dispensing system via the Surescripts network."

PSS Dispensing is one of the nation's largest point-of-care treatment solution providers. Solutions include high quality pre-packaged medications that deliver quality patient care and improved patient compliance.

PSS Dispensing offers:

• The latest in regulatory and compliance information;
• Large formulary of medications to customize according to practice needs;
• FDA approved pre-packaged medication in "unit-of-use" quantities; and
• VAWD accredited, DEA- and FDA-approved facilities.

About PSS World Medical

PSS World Medical, Inc. markets and distributes medical products and services to front-line caregivers throughout the United States. With 4,000 team members, PSS is a leader in the markets it serves with innovative approaches to customer service and operational excellence. Its stated purpose is to strengthen the clinical success and financial health of caregivers by solving their biggest problems. The Company is focused to accelerate growth in four markets – Physician, Laboratory, Dispensing, and Home Care & Hospice – with products and solutions that deliver high quality, cost effective, and convenient patient care. For more information on PSS, visit www.pssworldmedical.com .

The PSS World Medical, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13669

Certain statements in this release are "forward-looking statements" made pursuant to the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements are identified by the use of words such as "expect," "may," "will," "should," "believe," "plan," "anticipate," and "estimate" among others, and specifically include statements regarding the plans, strategies and objectives of management for future operations, including execution of restructuring plan or plans, and the additional investment in, and disposition of, certain business operations; statements or projections of cost savings, growth rates, profitability, investment levels or other financial items; statements regarding anticipated operational and financial results; and any statements of assumptions underlying any of the foregoing. These statements involve a number of risks and uncertainties, many of which are outside the control of the Company. Actual results may differ materially from those identified in the forward-looking statements and other factors described from time to time in the Company's reports filed with the Securities and Exchange Commission. PSS World Medical, Inc. assumes no obligation to update the information in this release except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.

CONTACT: Jenny Kobin
         Vice President, Investor Relations
         904-332-3287